RECRUITING

Diffusion Basis Spectrum Imaging of the Prostate

Description

Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

Conditions

Prostate Cancer
Talk to us

Related Conditions:

Prostate Cancer

Study Overview

On this page

Study Details

Study overview

Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

Diffusion Basis Spectrum Imaging of the Prostate: A Virtual Biopsy to Accurately Diagnose Prostate Cancer

Diffusion Basis Spectrum Imaging of the Prostate

Condition
Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

Saint Louis

Washington University School of Medicine, Saint Louis, Missouri, United States, 63110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Over 18 years of age and willing and able to provide informed consent.
  • * Patients with no prior diagnosis of prostate cancer, who are planning to undergo prostate biopsy as clinical standard of care ("early detection cohort")
  • * Including those men with:
  • * an elevated PSA and no prior biopsy
  • * an elevated PSA and a negative prior biopsy
  • * Patients with a prior diagnosis of prostate cancer, who are currently managed with active surveillance, who are planning to undergo biopsy as clinical standard of care ("active surveillance cohort")
  • * Patients with any clinical contraindication to MRI
  • * Those with metallic implants, such as pacemakers or implantable cardioverter-defibrillators
  • * Those with cochlear implants
  • * Those with claustrophobia not relieved with medications (patients with claustrophobia who do not need medications for the scan or whose claustrophobia can be managed with medication, are eligible to participate)
  • * Those who cannot lie flat for over 1 hour
  • * Patients with prior prostate surgery for prostate cancer (e.g. radical prostatectomy, focal ablation)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Washington University School of Medicine,

Joseph Ippolito, M.D., PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

2027-05-31